cardiomyopathy
To date, only       beta adrenoceptor blockers have been shown to improve survival in post-MI       patients as well as in patients with cardiomyopathy and CHF.
To date, only       beta adrenoceptor blockers have been shown to improve survival in post-MI       patients as well as in  @OBJECT$   @PREDICAT$   @SUBJECT$  and CHF.